Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.35 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.35 |
| ▸ | RHOA | P61586 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1100931 | 0.76 | SNCA (0.38) | CYP3A4NPSR1TSHRALDH1A1HSD17B10 | |
| SCHEMBL1109685 | 0.73 | ALDH1A1 (0.43) | TSHRALDH1A1HSD17B10LMNAMAPK1 | |
| SCHEMBL10510973 | 0.72 | NPSR1 (0.53) | CYP3A4NPSR1TSHRALDH1A1HSD17B10 | |
| SCHEMBL5533588 | 0.72 | CYP3A4 (0.43) | CYP3A4NPSR1TSHRALDH1A1HSD17B10 | |
| SCHEMBL28099494 | 0.71 | — | — | |
| SCHEMBL27810242 | 0.71 | ALDH1A1 (0.42) | TSHRALDH1A1HSD17B10LMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL29837126 | 0.71 | ALDH1A1 (0.42) | TSHRALDH1A1HSD17B10LMNAMAPK1 | |
| Benzene SCHEMBL3212029 | 0.70 | CYP3A4 (0.54) | CYP3A4NPSR1TSHRALDH1A1HSD17B10 | |
| SCHEMBL13712855 | 0.69 | TSHR (0.46) | CYP3A4NPSR1TSHRALDH1A1HSD17B10 | |
| SCHEMBL9233374 | 0.69 | ALDH1A1 (0.33) | ALDH1A1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115911544-B | Nonaqueous electrolyte and lithium battery | 张家港市国泰华荣化工新材料有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-115911544-A | Non-aqueous electrolyte and lithium battery | 张家港市国泰华荣化工新材料有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-105985389-B | Phenylethanoid glycoside analogue and synthesis method and application thereof | 北京大学 | 2019-03-19 | — | — | CN | claimed |
| CN-115911544-B | Nonaqueous electrolyte and lithium battery | 张家港市国泰华荣化工新材料有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-115911544-A | Non-aqueous electrolyte and lithium battery | 张家港市国泰华荣化工新材料有限公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-2471796-B1 | NOVEL ADDUCT COMPOUND, SOLUTION FOR FORMATION OF ORGANIC SEMICONDUCTOR FILM, METHOD FOR PRODUCING SAID SEMICONDUCTOR FILM AND METHOD FOR SYNTHESIZING SAID ADDUCT COMPOUND | TEIJIN LTD (JP) | 2019-10-30 | — | — | EP | disclosed |
| CN-105985389-B | Phenylethanoid glycoside analogue and synthesis method and application thereof | 北京大学 | 2019-03-19 | — | — | CN | disclosed |
| CN-108774274-A | Sialic acid methyl esters first glycoside derivates and its synthetic method and application | 北京大学 | 2018-11-09 | — | — | CN | disclosed |
| CN-108752212-A | 9- decarboxylation Rosmarinic acid analogs and its synthetic method and application | 北京大学 | 2018-11-06 | — | — | CN | disclosed |
| US-9056871-B2 | Adduct compound, methods for purification and preparation of fused polycyclic aromatic compound, solution for formation of organic semiconductor film, and novel alpha-diketone compound | TEIJIN LIMITED (JP) | 2015-06-16 | — | — | US | disclosed |
| US-20120211731-A1 | NOVEL ADDUCT COMPOUND, METHODS FOR PURIFICATION AND PREPARATION OF FUSED POLYCYCLIC AROMATIC COMPOUND, SOLUTION FOR FORMATION OF ORGANIC SEMICONDUCTOR FILM, AND NOVEL ALPHA-DIKETONE COMPOUND | TEIJIN LIMITED (JP) | 2012-08-23 | — | — | US | disclosed |
| EP-2471796-A1 | NOVEL ADDUCT COMPOUND, METHODS FOR PURIFICATION AND PREPARATION OF FUSED POLYCYCLIC AROMATIC COMPOUND, SOLUTION FOR FORMATION OF ORGANIC SEMICONDUCTOR FILM, AND NOVEL -DIKETONE COMPOUND | Teijin Limited (JP) | 2012-07-04 | — | — | EP | disclosed |
| EP-1751233-A1 | ELECTROCONDUCTIVE COMPOSITION AND APPLICATION THEREOF | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005113678-A1 | ELECTROCONDUCTIVE COMPOSITION AND APPLICATION THEREOF | SHOWA DENKO K.K. (JP) | 2005-12-01 | — | — | WO | disclosed |
| US-4511575-A | Antidiabetic pyrrolecarboxylic acids | PFIZER INC. (US) | 1985-04-16 | — | — | US | disclosed |
| US-4511576-A | Antidiabetic pyrrolecarboxylic acids | PFIZER INC. (US) | 1985-04-16 | — | — | US | disclosed |
| US-4351843-A | LOWERING BLOOD GLUCOSE | PFIZER INC. (US) | 1982-09-28 | — | — | US | disclosed |
| US-4282242-A | HYPOGLYCEMIC AGENTS | PFIZER INC. (US) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120211731-A1 | NOVEL ADDUCT COMPOUND, METHODS FOR PURIFICATION AND PREPARATION OF FUSED POLYCYCLIC AROMATIC COMPOUND, SOLUTION FOR FORMATION OF ORGANIC SEMICONDUCTOR FILM, AND NOVEL ALPHA-DIKETONE COMPOUND | DDT, SULT1A1, KCNT1 | CYP3A4 1099/4885NPSR1 3648/4885TSHR 4202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.